Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
—1,092.741,095.951,103.321,094.72——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
—613.36613.36613.36609.50——
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
—1,176.791,176.521,182.251,166.69——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
—1,755.541,759.231,766.301,746.04——
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
—635.15635.20636.89630.09——
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
—848.01852.52855.78849.58——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
—217.86217.86219.52217.86——
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
—3,417.353,452.773,536.033,450.39——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
—913.36915.10920.43904.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
—1,462.381,461.131,464.531,446.02——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
—2,423.142,428.712,448.692,424.63——
Q4 2026 earnings • released • EPS beat +4.93% • Revenue beat +11.73%
See results
AJANTPHARM:NSE
Ajanta Pharma Ltd
₹3,033.00
-1.47%
(-45.40) 1D
May 8, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AJANTPHARM...
Open
₹3,079.80
High
₹3,095.00
Low
₹3,027.70
Mkt. cap
379.18B
Avg. vol.
95.86K
Volume
55.92K
Dividend
1.38%
Quarterly dividend
₹10.50
Ex dividend date
Nov 10, 2025
P/E ratio
35.89
52-wk high
₹3,228.00
52-wk low
₹2,329.90
EPS
₹84.51
Shares outstanding
88.45M
No. of employees
10K
News stories
From sources across the web
Profile
Ajanta Pharma Limited is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973.. Wikipedia
About Ajanta Pharma Ltd
CEO-
Employees9.63K
Founded1973
Headquarters-
SectorPharmaceutical industry
Websiteajantapharma.com
Last report
May 5, 2026
Fiscal Period
Q4 2026
EPS / Est. (INR)
₹21.34 / ₹20.34
+4.93%beat
Revenue / Est. (INR)
14.83B / 13.27B
+11.73%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
13.03B
13.54B
13.75B
14.83B
Cost of goods sold
2.76B
3.17B
2.86B
3.05B
Cost of revenue
2.76B
3.17B
2.86B
3.05B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.03B
3.17B
3.31B
3.41B
Operating expense
6.92B
7.11B
7.50B
8.29B
Total operating expenses
9.67B
10.28B
10.36B
11.34B
Operating income
3.35B
3.26B
3.39B
3.49B
Other non operating income
169.50M
197.10M
164.20M
-
EBT including unusual items
3.31B
3.41B
3.59B
3.47B
EBT excluding unusual items
3.31B
3.41B
3.59B
3.47B
Income tax expense
757.90M
806.20M
848.30M
804.10M
Effective tax rate
22.89%
23.66%
23.66%
23.17%
Other operating expenses
3.47B
3.51B
3.76B
4.43B
Net income
2.55B
2.60B
2.74B
2.67B
Net profit margin
19.60%
19.22%
19.91%
17.98%
Earnings per share
20.43
20.82
21.91
21.34
Interest and investment income
-
-
-
-
Interest expense
-52.60M
-33.90M
-51.00M
-23.60M
Net interest expenses
-52.60M
-33.90M
-51.00M
-23.60M
Depreciation and amortization charges
412.90M
429.70M
435.10M
453.70M
EBITDA
3.66B
3.68B
3.70B
3.93B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer